GV 150526A

Known as: GV-150526A, GV150526, GV150526A 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2006
024619972006

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
BACKGROUND AND PURPOSE Gavestinel, GV150526, is a selective antagonist at the glycine site of the N-methyl-D-aspartate receptor… (More)
Is this relevant?
2002
2002
During cerebral ischaemia, glutamate is released in supraphysiological amounts and is toxic to brain tissue. This excitotoxicity… (More)
Is this relevant?
2002
2002
Gavestinel [GV150526A; ( E)-3[(phenylcarbamoil)ethenyl]-4,6-dichloroindole-2-carboxylic acid sodium salt] is a selective… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
CONTEXT Elucidation of the ischemic cascade has helped stimulate development of neuroprotective drugs aimed at limiting brain… (More)
Is this relevant?
2001
2001
GV150526 is a novel glycine antagonist at the NMDA receptor complex. It is a potent neuroprotective agent in animal models of… (More)
Is this relevant?
1999
1999
BACKGROUND AND PURPOSE GV150526 is a novel glycine site antagonist at the N-methyl-D-aspartate receptor complex. It is a potent… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
1999
1999
The utility of interspecies scaling in early drug development has been extensively debated. The authors discuss the dose… (More)
Is this relevant?
1997
1997
The neuroprotective activity of the novel, selective glycine antagonist GV150526 was assessed in the middle artery occlusion… (More)
Is this relevant?
1997
1997
The effect of selective antagonists (7-Cl-kynurenic acid, 3-amino-1-hydroxypyrrolid-2-one (HA 966) and GV 150526A) at strychnine… (More)
Is this relevant?
1997
1997
The N-methyl-D-aspartate (NMDA) receptor is a ligand-gated ion channel which is widely distributed in the central nervous system… (More)
Is this relevant?